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Abstract 
An essential component of animal cells, cholesterol exerts significant influence on 
the physical properties of the cell membrane and in turn, its constituents. One such 
category of constituents, the membrane proteins, are responsible for diverse and essential 
biological functions and often contain polar amino acids. Although sparse within the 
hydrophobic interior of lipid-bilayer membranes, polar amino acid residues are highly 
conserved and may play pivotal roles in determining specific structural and functional 
properties of key proteins. To gain greater understanding of the lipid membrane 
environment, and more broadly, cellular function, a model peptide framework termed 
“GWALP23” (acetyl-GGALWLALALAL12AL14ALALWLAGA-amide) can be useful. 
Designed and created at the University of Arkansas, the peptide is composed of amino 
acid residues of glycine (G), tryptophan (W), alanine (A), and leucine (L). The central 
helical core consisting of the W(LA)6LW sequence is critical for defining the 
transmembrane configuration of this host peptide framework. Furthermore, the limited 
dynamic averaging of NMR observables such as the deuterium quadrupolar splittings of 
labeled alanine residues makes GWALP23 favorable for examining the influence of 
single “guest” residue replacements within the core sequence. Previously, GWALP23 
family peptides were characterized with single leucine to arginine (R) mutations at 
positions 12 and 14 in single-lipid membranes.1 GWALP23-R14 adopts a defined tilted 
orientation in DOPC bilayers, whereas GWALP23-R12 displays multi-state behavior.1 
The goal of this research is to further characterize these peptides in cholesterol-containing 
lipid bilayers. Specific deuterium-labeled alanine residues were incorporated into the R12 
and R14 sequences to identify transmembrane peptide orientations by means of solid-
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state deuterium NMR spectroscopy. The peptides were incorporated into phospholipid 
bilayers with varying cholesterol content (0%, 10%, or 20%). Our findings suggest that 
10% or 20% cholesterol content has minimal impact on the orientation of the GWALP23-
R14 peptide. (Although the NMR signals are broader and weaker in the presence of 20% 
cholesterol, the deuterium quadrupolar splittings for 2H-Ala residues in GWALP23-R14 
change little.) Conversely, cholesterol appears to reduce the multi-state behavior of 
GWALP23-R12, favoring a single well-defined state for the helix. With 10% or 20% 
cholesterol content, the spectra exhibit defined quadrupolar splittings, suggesting that 
GWALP23-R12 adopts a predominant orientation at the membrane surface in the 
presence of cholesterol. These results convey a conditional sensitivity of a complex 
multi-state peptide helix to the presence of cholesterol. 
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Abbreviations 
CD, circular dichroism; DLPC, 1,2-dilauroylphosphatidylcholine; DMPC, 1,2-
dimyristoylphosphatidylcholine;	DOPC, 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine; 
Fmoc, fluorenylmethoxycarbonyl; GALA, geometric analysis of labeled alanines; 
GWALP23, acetyl-GGALW(LA)6LWLAGA-[ethanol]amide; HPLC, high-performance 
liquid chromatography; kHz, kilohertz;  MALDI-TOF, matrix-assisted laser 
desorption/ionization-time of flight; MtBE, methyl-t-butyl ether; NMR, nuclear magnetic 
resonance; TFA, trifluoroacetic acid; TFE, 2,2,2-trifluoroethanol; TIPS, triisopropylsilane 
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Introduction 
 Upon the discovery and continuing investigations of their vital roles in both disease 
and basic cell functioning, membrane-bound proteins have become an increasingly 
important focus of scientific research. Essential to many membrane proteins are polar 
amino acids, which often determine the structure and function of the protein itself. The 
particular sequence and length of a largely hydrophobic membrane protein determines its 
behavior and stability within the cell membrane. Interestingly, the more sparse polar 
amino acids may be critical for particular functional properties. The examination of polar 
amino acids is possible through the use of synthetic model peptides such as those of the 
“GWALP” family. The GWALP peptides were 
created from an original “WALP” model peptide 
family by reducing the number of tryptophan (W) 
residues. WALP contained four aromatic W 
residues that serve as anchors for the membrane-
spanning helix.2,3,4 Although the WALP peptides 
have been useful for studying peptide mismatch, 
their high dynamics made them less than ideal for 
studying the effects of single residue replacement 
within the peptide core.5  
 GWALP23 was developed as a control and 
was found to decrease the high dynamics of WALP 
(Figure 1). By including only two anchoring 
tryptophan residues (W) rather than the four contained in WALP, greater stability and 
Figure 1. 3D representation 
of model peptide GWALP23. 
The indole rings extending 
from the right side are W5 and 
W19 in the 23-residue 
sequence.   
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lower dynamics were achieved.6,7 GWALP23 (GGALW(LA)6LWLAGA) contains a 
single tryptophan residue at each end (positions 5 and 19) and a repeating leucine-alanine 
helical core sequence.8,9 The leucine-alanine helical core prefers the hydrophobic 
environment of the membrane, while the tryptophan residues prefer a location near the 
lipid-water interface.10 GWALP23 and related model peptides fold into helices and adopt 
defined tilted orientations that can be observed in bilayer membranes by means of solid-
state NMR spectroscopy. The solid-state NMR spectra allow for investigations of just 
one “guest” residue, such as a strongly polar or charged amino acid within the central 
core of the transmembrane helix. The constrained dynamics of GWALP23 make it more 
favorable than many other candidate “host” peptides for studies of specific guest residues.  
 Alanine residues within the GWALP23 core are labeled with deuterium in order to 
study the dynamics and orientation of the peptide by means of solid-state deuterium (2H) 
NMR spectroscopy. For convenience and experimental efficiency, alanine residues are 
labeled in pairs in core positions as 
follows: 7 and 9, 11 and 13, or 15 and 17. 
Within the alanine pairs that are labeled, 
the alanine closest to the N terminus is 
labeled with 50% deuterium. The other 
alanine is labeled with 100% deuterium. 
This is so that quadrupolar splittings in 
NMR spectra may be distinguished and 
assigned, as shown in Figure 2. 
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Ala 100% 
Ala 50% 
50 
Figure 2. Deuterated alanine residues 
are incorporated into the core of the 
peptide with 50% or 100% relative 
abundance to distinguish the 
quadrupolar splittings by solid-state 
deuterium NMR spectroscopy. 
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 The first focus of this project is to study the effects of replacing a single 
hydrophobic leucine residue (L) with the very polar, and positively charged, arginine (R) 
at position 14 of the GWALP23 peptide. Previous experiments have shown that R14 
causes a 10° change in helix tilt, which is invariant over a pH range of 4 to 9, where the 
arginine is charged.1 The equivalent peptide with lysine at position 14 (GWALP23-K14) 
shows an interesting pH-dependent tilt that indicates a pKa of 6.5 for the lysine at 37°C in 
membranes of DOPC.11 Based on the established titration of the lysine, my project has 
focused on extending the NMR observations for GWALP23-R14 to higher pH, by using 
bilayers composed of the more stable ether-linked lipids. The ether-linked DOPC bilayers 
are used as a means of preventing the base-catalyzed hydrolysis of ester lipids. Deuterium 
labels are incorporated in alanine residues 15 and 17 in GWALP23-R14 and the 
magnitude and orientation of the helical tilt was assessed using solid-state deuterium 
NMR spectroscopy at pH 9.5 and above.   
 This research project has also been directed to studying GWALP23-R14 and 
GWALP23-R12 in cholesterol-containing lipid bilayer membranes. Calculations based 
on questionable approximations for the lipid-bilayer environment have suggested that 
cholesterol may have a direct effect on the pKa of buried arginine residues; perhaps 
shifting the pKa of arginine from 12.5 to 3.8 in the presence of cholesterol.12 Using a 
combination of DOPC phospholipids and cholesterol, I conducted experiments on 
GWALP23-R14 and GWALP23-R12 using 0%, 10%, and 20% cholesterol content 
(relative to the major lipid component DOPC) in the lipid bilayer.  
 The results of this research are important for understanding the effect of a changing 
chemical environment on the ionization behavior of arginine and, more generally, the 
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basic properties of proteins in cell membranes. Arginine plays an important role in cell-
to-cell communication. If the functioning of arginine is better understood in a realistic 
cell environment, this will serve as an invaluable resource for computational scientists 
modeling arginine-containing systems, as well as for researchers working to advance 
drug design and delivery mechanisms. The sequences of model peptides used in this 
research are shown in Table 1 and cartoon representations of peptides GWALP23-R12 
and GWALP23-R14 are displayed in Figure 3. 
  
Figure 3. Side view and top-down 
representations of peptides (A) GWALP23-R12 
and (B) GWALP23-R14. 
A B 
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Table 1. Model Peptide Sequences: Table 1 displays the sequence of model peptide 
GWALP23 as well as the sequences of model peptides I have synthesized (GWALP23-
R12 and GWALP23-R14). Deuterated alanine residues are denoted as A#. 
Peptide Name Sequence 
GWALP23 acetyl-GGALWLALALALALALALWLAGA-amide 
GWALP23-R12 acetyl-GGALWLA
7LA9LARALALALWLAGA-amide 
 
GWALP23-R12 acetyl-GGALWLALALARALA
15LA17LWLAGA-amide 
 
GWALP23-R14 acetyl-GGALWLALALA
11LA13RALALWLAGA-amide 
 
GWALP23-R14 acetyl-GGALWLALALALARA
15LA17LWLAGA-amide 
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Materials and Methods 
Solid Phase Peptide Synthesis 
 Peptides containing deuterium-labeled alanine residues were synthesized using 
an Applied Biosystems 433A Peptide Synthesizer.13 Fmoc-ala-d4 was created and 
recrystallized in the lab, using a process which takes several weeks.8 To create peptides 
by solid-phase peptide synthesis, 0.57 mmole of each amino acid in the peptide sequence 
was obtained (weighed with a balance) and placed in an individual cartridge (one per 
amino acid). The two alanine residues in the peptide sequence labeled with deuterium 
were labeled in different proportions. One alanine was labeled with 50% deuterium 
(0.285 mmoles of Fmoc-ala-d4 and 0.285 mmoles of alanine) and the other was labeled 
with 100% deuterium (0.57 mmoles Fmoc-ala-d4). Alanine residues were labeled in pairs 
at positions 7 and 9, 11 and 13, and 15 and 17. The amino acid cartridges are placed in 
order from C to N-terminal in the delivery system of the peptide synthesizer. Thus, 
peptides are synthesized from the carboxyl terminus back to the amino terminus. 
“FastMoc” chemistry method was used to remove blocking groups, couple the amino 
acids in the proper order, and thereby perform the peptide synthesis.  
Peptide Cleavage  	 Following completion of peptide synthesis, the peptide is cleaved using a 
trifluoroacetic acid (TFA) cleavage cocktail, which is composed of 
TFA:TIPS:H2O:phenol in a ratio of 85:5:5:5 (v/v, or w/v for phenol).14 To begin the 
cleavage, approximately 100 mg of resin with peptide attached is weighed and placed in a 
glass scintillation vial. Next, the TFA cleavage cocktail is added to the resin. The vial is 
wrapped in foil and placed on a shaker for 3 hours at room temperature. Afterward, the 
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resin is transferred with a plastic pipette to short glass Pasteur pipette containing glass 
wool. The glass wool is used as a filter to separate peptide from the resin. The filter is 
rinsed with 2 mL of TFA and purged using a plastic pipette. Afterwards, the peptide 
solution is dried under nitrogen gas flow until approximately ¼ of the volume remains. 
The peptide product is then transferred to a 50 mL plastic centrifuge vial and is 
precipitated with 25 mL of methyl-t-butyl ether:hexane solution on ice for 30 minutes. 
The solution is centrifuged at 4°C for 10 minutes at approximately 1500 RPM. The 
supernatant is discarded and the pellet is re-suspended in 25 mL methyl-t-butyl 
ether:hexane. This procedure is repeated twice more. After the final centrifugation, the 
supernatant is poured off and the pellet is dried under a low flow stream of nitrogen gas. 
The final product is lyophilized overnight to a white powder from 2 mL of 
acetonitrile/water. 
Crude Peptide Quantitation and Purification 
 After the peptide has been cleaved from the resin, the amount of recovered 
peptide is determined. First, 0.5 mL of TFE is added to the centrifuge tube containing the 
dried peptide to dissolve the peptide and begin the quantitation process. A UV-Vis 
sample is prepared from mixing 2 µL of the peptide/TFE mixture with 1.5 mL of 
methanol. The UV-Vis is first run with a blank of methanol and is set to read at 280 nm. 
After a sample is run, the spectra and optical density at 280 nm allows for calculation of 
total milligrams of peptide present. Next, an analytical HPLC sample is prepared from a 1 
µL aliquot of the peptide solution diluted to 1 mg/mL with TFE. This is injected into the 
analytical HPLC and is called a “test injection.” The analytical HPLC reveals a spectrum 
that indicates peptide impurities. This is useful for determining a method for collection of 
	 -14- 
pure peptide. Another sample is prepared from the dried peptide/TFE mixture for mass 
spectrometry. This is created from a 50 µL aliquot and 450 µL of additional TFE. This 
sample vial is sent to the Arkansas Mass Spectrometry facility for analysis. The MALDI-
TOF mass spectrometry profile confirms the peptide molecular mass and deuteration 
pattern. Finally, the remaining peptide solution is ready for purification by semi-
preparative HPLC. Reversed-Phase High Performance Liquid Chromatography (RP-
HPLC) is run with the Hitachi L1700 system and a Zorbax RX-C8 column (9.4 mm x 
250 mm) from Agilent Technology. The HPLC must initially be purged with methanol 
and a desired gradient set to 92-96% for GWALP23. A test sample of 10 µL is injected 
into the HPLC for determination of the peak positions on the spectrum. The time the peak 
occurs corresponds to the time the peptide will be collected from the HPLC. After the test 
injection, the range of the HPLC detector is changed to 10 and a 300 µL aliquot of 
peptide is injected. The pure peptide product is collected approximately 15 minutes after 
the injection. Once collected, the aqueous product is dried under nitrogen until only a 
white film remains. Quantitation is performed again to determine the amount of pure 
peptide collected. For this process, the peptide film first is dissolved in 1 mL of TFE. A 
UV-Vis sample is created with 10 µL of dissolved peptide and 990 µL of methanol. The 
optical density at 280 nm is used again to calculate the total mass of pure peptide in 
milligrams. A sample of the peptide is sent once again to the Arkansas Mass 
Spectrometry facility for analysis by MALDI-TOF mass spectrometry. This sample is 
prepared using a 50 µL aliquot of peptide and 450 µL of TFE. Finally, the peptide is 
aliquoted for initial sample preparation for solid-state 2H NMR and circular dichroism 
spectroscopy. Solid-state 2H NMR samples require 1.3 µmol of peptide. The CD samples 
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need 0.0625 µmol of peptide. The remaining pure peptide and the aqueous samples are all 
dried under nitrogen until only a film remains. Lastly, any remaining pure peptide not 
aliquoted for samples is lyophilized. To lyophilize, 0.5 mL of acetonitrile and 0.5 mL of 
water is added to the peptide film and the solution is immersed in liquid nitrogen. The 
frozen centrifuge tube is then left under vacuum overnight.  
Mass Spectrometry 
 A MALDI-TOF (matrix-assisted laser desorption ionization, time of flight) mass 
spectrum reveals the peptide mass and deuteration pattern. If correct, this pattern will 
confirm the identity of the peptide created by solid-phase peptide synthesis. The mass 
spectrometry is conducted by the Arkansas Statewide Mass Spectrometry Facility at the 
University of Arkansas. The satellite peaks in the spectrum correspond to ionization 
states of the peptide. As described in the “Crude Quantitation and Purification” section, 
mass spectrometry samples can be prepared both before and after peptide purification by 
semi-preparative HPLC. 
Circular Dichroism Spectroscopy 
 Circular dichroism (CD) spectroscopy for samples in the lipid bilayer 
environment may be used to confirm the secondary structure of the peptides created by 
solid-state peptide synthesis. To create CD samples, peptide is incorporated into small 
unilamellar lipid vesicles (SUVs) in DLPC, DMPC or DOPC lipids. These samples 
require 0.0625 µmol of pure peptide, and peptide is added in a 1:40 peptide to lipid ratio. 
1 mL of acetonitrile:water (50:50) solution is added to the peptide. Next, 2.5 µmols of 
lipid is added to the peptide and acetonitrile:water solution. This mixture is then dried 
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under nitrogen gas until a film remains. Finally, the samples are put under vacuum for 
~48 hours to remove solvent. 
Oriented Sample Preparation 
Samples are created for analysis by NMR spectroscopy through preparation in a 
1:40 peptide:lipid ratio. Samples can be prepared using DLPC, DMPC, and DOPC lipid 
membranes and cholesterol. However, the focus of this project has used DOPC 
phospholipids and cholesterol only. The samples are comprised of 1.3 µmols of peptide 
and 90 µmols of lipid with 45% hydration (w/w-water/peptide-lipid). After the lipids are 
added to dried peptide, the sample is dried under nitrogen gas. Once dry, 1 mL (95% 
methanol and 5% water) is added to the dried peptide/lipid combination. To create 
samples, 40 glass slides are dispersed in two petri dishes (20 glass slides per petri dish). 
A 50 µL syringe is used to add 25 µL peptide/lipid solution to each glass slide. Once the 
peptide/lipid solution is evenly dispersed on all slides, the open petri dishes are covered 
with glass lids and dried under vacuum in a dessicator for 48 hours. The second step of 
oriented sample preparation is hydrating and stacking the glass slides. Approximately 1.2 
µL of deuterium-depleted water or buffer is used to hydrate the glass slides. The water 
must be free of deuterium so that the only deuterium present in the system is the 
deuterium-labeled alanine residues in the peptide core. The hydrating liquid is added as 
approximately 3 drops to each slide. Once a slide has been hydrated with water or buffer, 
it is stacked on another slide and carefully pressed down with tweezers. This pressure 
helps to mechanically form a lipid bilayer stack between the slides. The final result is a 
single stack of glass slides that is placed in a cuvette and sealed with a glass top using 
epoxy glue. The cuvette is sealed twice to ensure a complete seal and is then placed in a 
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dark heating plate at 40°C for several days to achieve orientation of liquid-crystalline 
lipid bilayers. The sample is removed when it appears clear. The oriented sample 
preparation process is illustrated in Figure 4. 
31P NMR Spectroscopy 
 31P (phosphorous) NMR spectroscopy verifies bilayer alignment of oriented 
samples by monitoring the lipid head groups. Samples are run at 50 °C on a Bruker 
Avance 300 spectrometer at both β=0° and β=90° orientation. At β=0°, the bilayer normal 
is parallel to the applied magnetic field. At β=90°, the bilayer normal is perpendicular to 
the magnetic field. 
Solid-State 2H NMR Spectroscopy 
 Solid-state 2H NMR spectroscopy is conducted similarly to 31P NMR 
spectroscopy. Samples are run at 50 °C on a Bruker Avance 300 spectrometer at both 
β=0° and β=90° orientations. Resulting spectra display peaks that can be used to measure 
the respective 2H quadrupolar splittings. These measurements are important in 
determining information about the peptide tilt and rotation in various lipid environments.  
7
6
5
4
3
2
1
10
9
835
30
25
20
15
10
5
50
45
40
β=90° 
β=0° 
1. 2. 
3. 4. 
Figure 4. Visual representation of oriented NMR sample preparation. (1) First, the 
peptide/lipid mixture is applied to glass slides. (2) Next, the glass slides are hydrated 
with deuterium-depleted water or buffer and stacked. (3) Third, the glass slides are 
placed in a cuvette and sealed. (4) Finally, the oriented sample is placed in the NMR 
probe at 90° or 0° with respect to the magnetic field. 
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Figure 6. Circular dichorism spectra for 
peptides in DLPC vesicles. GWALP23-R14 
is shown in black and GWALP23-R12 is 
shown in red. Both spectra are representative 
for peptides that are alpha-helical. 
Results 
 
After GWALP23-R12 and 
GWALP23-R14 peptides were 
synthesized and purified, MALDI-TOF 
mass spectrometry was used to confirm 
the molecular mass and deuteration pattern. 
The expected molecular mass of 2304 + 
~8 deuterons was confirmed for the two 
peptides, as shown in Figure 5. (The 
individual peaks within the “4D” (four 
deuteron) and “8D” envelopes in Figure 5 
represent integral differences in the 
content of 13C, which has 1.1% natural 
abundance.)  
 Next, the peptides were 
analyzed using circular dichroism 
(CD) spectroscopy to confirm peptide 
secondary structure. The repeating 
Leu-Ala sequence of the GWALP23 
peptide core forms an alpha-helical 
secondary structure in the hydrophobic 
region of the lipid bilayer. The CD 
spectra for both the R12 and R14 peptides shown in Figure 6 are characteristically alpha-
Figure 5. MALDI-TOF mass spectrum 
for GWALP23-R12. GWALP23-R14 
gives the same spectrum because its 
molecular weight and composition is 
identical. 
2312.3 
+4 D 
+8 D 
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helical. The helicity is indicated by the presence of minima at approximately 208 nm and 
222 nm. 
Phosphorous NMR (31P NMR) is used to confirm lipid bilayer alignment in 
oriented samples. 31P NMR spectra display a single well-defined peak at +28 ppm for β = 
0° (membrane normal parallel to the applied magnetic field) or -14 ppm for β = 90° 
(membrane normal perpendicular to the applied magnetic field) for samples with proper 
bilayer alignment. Smaller secondary peaks can occur in the β = 0° spectra, which 
indicates some lipid unalignment. This occurs because the β = 0° orientation is more 
sensitive to lipid alignment.  Representative 31P spectra for three distinct peptide-lipid 
conditions are displayed in Figure 7. 
DOPC + 20% cholesterol 
(lipid only) 
GWALP23-R14:DOPC + 10% cholesterol 
(1:60) 
GWALP23-R14:DOPC + 20% cholesterol 
(1:60) 
β=90° β=0° 
Figure 7. From top spectrum: 31P NMR spectra of GWALP23-R14 with 90% DOPC 
and 10% cholesterol content; DOPC with 20% cholesterol content (no peptide); 
GWALP23-R14 with 80% DOPC and 20% cholesterol. Samples containing peptide and 
lipid are composed in a 1:60 peptide:lipid molar ratio. Well-defined single peaks in β = 
90° and β = 0° spectra indicate that the lipid bilayer is aligned.  
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Peptide behavior and orientation is assessed in various bilayers by studying 
oriented samples with solid-state 2H NMR spectroscopy to monitor the side-chain methyl 
groups of the labeled alanine residues. Prior to the addition of cholesterol, GWALP23-
R14 was investigated over an extensive pH range of 2-13. This was to establish the limits 
for the pKa of arginine in a lipid bilayer. The results of these experiments are displayed in 
Figure 8 and indicate that the pKa of arginine is above 13. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pH 2.0 
pH 9.0 
pH 11.5 
pH 12 
pH 13 
Figure 8. 2H NMR spectra of GWALP23-R14 in DOPC ester or 
ether linked bilayers, over a pH range of 2-13.  Samples above pH 
8.5 required ether-linked lipids. Alanines 15 and 17 are deuterated 
at 50% and 100%, respectively. No significant changes in the 
quadrupolar splittings are observed between spectra.  
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Typically, ester-linked DOPC phospholipids are the lipid of choice for creating a 
model mammalian cell environment because they are natural phosphatidylcholine (PC) 
lipids. However, for the results displayed in Figure 8, the extreme pH conditions would 
lead to degradation of the ester-
linked lipids at high or low pH, 
by means of alkaline or acid 
hydrolysis to release the acyl 
chains. Ether-linked DOPC 
phospholipids were discovered to 
be suitable for replacement as 
they are resistant to acid and 
base-catalyzed degradation while 
providing a highly similar lipid 
environment. Small changes of 
0-2 kHz are observed in NMR 
spectra obtained from samples with DOPC bilayers formed with ether lipids rather than 
ester lipids, as shown in Figure 9.  
2H NMR experiments were then conducted at pH 5.5 to investigate the influence 
of 10% cholesterol content on the GWALP23-R14 peptide. The results of this experiment 
are displayed in Figure 10. No significant differences in the alanine methyl group 
quadrupolar splittings were observed between GWALP23-R14 in an environment of 
100% DOPC phospholipids and that of 90% DOPC and 10% cholesterol content, 
A 
B 
Figure 9. (A) 2H NMR spectra of GWALP23-R14 
with ether-linked DOPC phospholipids and with 
(B) ester-linked DOPC phospholipids.  
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suggesting that 10% cholesterol content does not affect the charge of arginine or the 
orientation and dynamic behavior of GWALP23-R14 in the bilayer membranes. 
 
 An experiment was also conducted to investigate the influence of 20% cholesterol 
on GWALP23-R14 at pH 5.5. The spectra obtained from this experiment are shown in 
Figure 11. Similar to the results displayed in Fig. 10, no significant differences in 
quadrupolar splittings were observed for GWALP23-R14 in an environment of 100% 
DOPC phospholipids and that of 80% DOPC and 20% cholesterol content. This suggests 
that 20% cholesterol content does not affect the charge of arginine or the behavior and 
dynamics of GWALP23-R14. 
β=90° β=0° 
Ala-15 
Ala-17 
Figure 10. 2H NMR spectra of (A) GWALP23-R14 with 100% DOPC and (B) 
GWALP23-R14 with 90% DOPC and 10% cholesterol content (B). Deuterated alanine 
residues in this experiment are Ala-15 and Ala-17. There are no significant differences 
in the quadrupolar splittings between spectra contained in (A) and (B). 
A 
B 
	 -23- 
 
Further 2H NMR experiments were conducted to investigate the influence of 
cholesterol on GWALP23-R12 at pH 5.5. GWALP23-R12 has been characterized 
previously in DOPC bilayers and was shown to display multi-state behavior.1 This means 
that the peptide molecules exist in a variety of different orientations within the lipid 
bilayer, including one populated state that moves to the membrane surface, rather than 
existing in primarily one single (tilted) transmembrane orientation. Multi-state 2H NMR 
spectra are characterized by low signal strength of peaks. Spectra obtained for the 
GWALP23-R12 peptide in 0%, 10%, and 20% cholesterol conditions with DOPC 
phospholipids are displayed in Figure 12.  In the presence of 10% and 20% cholesterol, 
the GWALP23-R12 helix transitions from multiple states in DOPC bilayers to instead 
occupy one major state (see Discussion).   
A 
B 
Ala-11 
β=90° β=0° 
Ala-13 
Figure 11. 2H NMR spectra of (A) GWALP23-R14 with 100% DOPC and (B) 
GWALP23-R14 with 80% DOPC and 20% cholesterol content (B). Deuterated alanine 
residues in this experiment are Ala-11 and Ala-13. There are no significant differences in 
the quadrupolar splittings between spectra contained in (A) and (B). 
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Ala-9 
Ala-7 
β=90° β=0° 
A 
B 
C 
Figure 12. 2H NMR spectra of (A) GWALP23-R12 with 100% DOPC (0% 
cholesterol), (B) GWALP23-R12 with 90% DOPC and 10% cholesterol 
content, and (C) GWALP23-R12 with 80% DOPC and 20% cholesterol 
content. Deuterated alanine residues in this experiment are Ala-7 and Ala-9. 
Spectra become more resolved in the presence of cholesterol. 
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Discussion 
This research project has resulted in several significant discoveries. Most notably, 
the pKa of arginine in a lipid bilayer was found to be above 13. Previously, the pKa of the 
arginine guanidinium group in aqueous solution has been considered to be ~12.5. This 
value dates from the 1920s, is cited in biochemistry textbooks and frequently is used in 
electrostatics calculations. Within the hydrophobic lipid bilayer interior, one might expect 
the arginine pKa to be lower, since the pKa for lysine in a DOPC bilayer is about 4 pH 
units lower than in aqueous solution.11 Nevertheless, my results indicate that the arginine 
pKa remains high in the lipid bilayer environment, perhaps because other mechanisms 
such as membrane deformation and helix translocation tend to ensure that hydration of 
the guanidinium group is maintained.1 This finding was corroborated by a striking recent 
publication which reported that the longstanding pKa  of arginine in aqueous solution 
should be revised to 13.8.15 The high pKa values for both aqueous and membrane-
incorporated arginine are particularly significant because a difference of a single pH unit 
corresponds to a 10-fold change in hydrogen ion concentration.  
 Secondly, it was discovered that ether-linked DOPC lipids can be substituted for 
ester-linked DOPC lipids in experiments that require extreme pH conditions. Spectra 
obtained from samples containing ether-linked lipids are nearly indistinguishable from 
spectra of samples containing ester-linked lipids. The ether-linked lipids display small 
changes of 0-2 kHz in the deuterium quadrupolar splittings, but they are a suitable 
replacement for ester-linked lipids due to their resistance to acid and base-catalyzed 
degradation.  
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 Thirdly, it was found that the pKa of arginine remains high, even in the presence 
of 10% and 20% cholesterol content in DOPC bilayers. The quadrupolar splittings of 2H-
labeled alanine side chains of GWALP23-R14 in a cholesterol-containing environment 
were not significantly different from those in an environment without cholesterol. This 
finding was particularly surprising because it is in direct opposition to the computational 
findings from Cui et al., who suggested through molecular dynamics simulations that the 
pKa of arginine may drop to 3.8 in the presence of cholesterol.12  
Although the pKa of arginine was shown to remain unchanged in the presence of 
cholesterol, in experiments with GWALP23-R12, the peptide itself was affected. 
GWALP23-R12 did not exhibit its characteristic multi-state behavior in DOPC 
membranes in the presence of cholesterol. With the addition of 10% and 20% cholesterol 
content, 2H NMR spectra became resolved, indicating that the peptide has a single 
primary orientation near the surface of the DOPC bilayers when cholesterol is present. 
The cholesterol effectively seems to drive GWALP23-R12 out of the bilayer interior and 
to the membrane surface. 
GWALP23 peptides serve as an invaluable model for studying the role of polar 
residues and transmembrane helices in a biologically relevant environment. The findings 
of this project are important for advancing computational modeling of arginine and 
arginine-containing proteins. For example, arginine is critical for the voltage-gating 
domains of potassium channels. These channels propagate electrical signals in the 
nervous system, which contribute to cellular communication. If both the pKa of arginine 
in a lipid bilayer and the role of cholesterol are better understood, more accurate 
computational models can be produced. This advancement is also important for drug 
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development. Many neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, 
are related to disruptions in cellular communication. If cellular function and the role of 
arginine in these systems is better understood, drug development for such diseases may 
be advanced. 
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